SPOTLIGHT -
Among the clues revealed in 3 recent studies: brain amyloid, saliva biomarkers, and microvascular dysfunction.
Alzheimer Disease Treatment Donanemab Receives FDA Approval
What Will the Future of Alzheimer Disease Treatment Look Like?
The Week in Review: June 10-14
Diagnosis and Treatment of Depressive and Memory Problems in Older Adults
Polypharmacy in Older Adults
The Week in Review: May 13-17